BBT Capital Management’s Pfizer PFE Stock Holding History

BBT Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-21,080	Closed	-$696K	–	195
2015 Q1	$696K	Buy	+21,080	New	+$670K	0.07%	135
2014 Q4	–	Sell	-105,400	Closed	-$2.96M	–	227
2014 Q3	$2.96M	Buy	+105,400	New	+$2.96M	0.16%	138
2014 Q1	–	Sell	-105,400	Closed	-$3.06M	–	321
2013 Q4	$3.06M	Hold	105,400	–	–	0.14%	169
2013 Q3	$2.87M	Hold	105,400	–	–	0.15%	162
2013 Q2	$2.8M	Buy	+105,400	New	+$2.91M	0.15%	161

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BBT Capital Management's PFE Position: Q3 2019 in Review

BBT Capital Management sold out of Pfizer (PFE) in Q3 2019, closing a stake of 10,605 shares — an estimated $436K sold.

BBT Capital Management first reported a position in PFE in Q2 2013 and held it in 4 quarters. The position peaked at $56.2M in Q2 2013. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

BBT Capital Management reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
BBT Capital Management sold 10,605 Pfizer shares in Q3 2019, an estimated $436K.
BBT Capital Management first reported a position in Pfizer in Q2 2013 and held it in 4 quarters.
BBT Capital Management's Pfizer position peaked at $56.2M in Q2 2013.
2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on BBT Capital Management's 13F filing for Q3 2019.